News Focus
News Focus
icon url

bob4uall

03/29/22 1:44 PM

#4153 RE: Edward #4152

Could you expand on what you said?:

For every million dollars that they raise from Keystone, appox.20 million shares would have to be issued using a market price of $.05.



Correct me if I'm wrong, but it would therefore take 25 x 20,000,000 shares to collateralize the whole loan, or 500,000,000 shares.

Potentially, if these became outstanding and held by the lender Keystone, they would own half of the company, right?

But I also assume that would only happen in a default.

Any comments on my suppositions are welcome.
icon url

DocSands

03/30/22 8:02 AM

#4162 RE: Edward #4152

Reg A dilution is going to kill this stock again. I can about guarantee if the stock is trading around a nickel, the cost basis for the Reg a shares will be .01 to .02.

I’m out. Don’t want to see this go back into the .01-.02 range.


icon url

bob4uall

06/08/22 10:50 AM

#4280 RE: Edward #4152

Rising authorized shares (potentially..dilutive) seem..to be..caused by..3 actions:
1. Helix House earn-out opportunity
2. Keystone equity line of credit
3. New company acquisition in progress, announced today

Diana15 alerted about the beginnings of this on her March 29 post.

I don't see why the share price hasn't anticipated much of this, so the potential dilution may be why we are seeing a price range trapped between $0.02 and $0.03 recently.

Looking forward, since the company is growing larger and the audited financials give some confidence, I expect growth will start raising the share price soon. Achieving the uplisting goal would be a key development. After all, why pay to audit a pink-sheets company?